ARCHIVES

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

This article is from The Cancer Letter archive.

Vol. 27 No. 04 | January 26, 2001

Download PDF Visit The Full Archive

Related Articles

NCI New Advisory Group Named On special Populations

June 25, 1999

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

March 5, 1999

Witnesses Seek 15% Boost For NCI In 1998 as First Step to 100% Raise Over 5 Years

May 9, 1997

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

April 17, 1987

California Hospital Raises $22 Million For New Cancer Center

September 14, 1990

Researchers Discover Bacteria Common in Colon Cancer Tissue

October 28, 2011